Chronic Unpredictable Mild Stress Induces Loss of GABA Inhibition in Corticotrophin-Releasing Hormone-Expressing Neurons through NKCC1 Upregulation

Neuroendocrinology. 2017;104(2):194-208. doi: 10.1159/000446114. Epub 2016 Apr 15.

Abstract

Introduction: Prolonged and repeated stresses cause hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis. The corticotrophin-releasing hormone (CRH)-expressing neurons in the hypothalamic paraventricular nucleus (PVN) are an essential component of the HPA axis.

Materials and methods: Chronic unpredictable mild stress (CUMS) was induced in Sprague-Dawley rats. GABA reversal potentials (EGABA) were determined by using gramicidin-perforated recordings in identified PVN-CRH neurons through expressing enhanced green fluorescent protein driven by the CRH promoter. Plasma corticosterone (CORT) levels were measured in rats implanted with a cannula targeting the lateral ventricles and PVN.

Results: Blocking the GABAA receptor in the PVN with gabazine significantly increased plasma CORT levels in unstressed rats but did not change CORT levels in CUMS rats. CUMS caused a depolarizing shift in EGABA in PVN-CRH neurons compared with EGABA in PVN-CRH neurons in unstressed rats. Furthermore, CUMS induced a long-lasting increase in expression levels of the cation chloride cotransporter Na+-K+-Cl--Cl- (NKCC1) in the PVN but a transient decrease in expression levels of K+-Cl--Cl- in the PVN, which returned to the basal level 5 days after CUMS treatment. The NKCC1 inhibitor bumetanide decreased the basal firing activity of PVN-CRH neurons and normalized EGABA and the gabazine-induced excitatory effect on PVN-CRH neurons in CUMS rats. In addition, central administration of bumetanide decreased basal circulating CORT levels in CUMS rats.

Conclusions: These data suggest that chronic stress impairs GABAergic inhibition, resulting in HPA axis hyperactivity through upregulation of NKCC1.

MeSH terms

  • Animals
  • Bumetanide / administration & dosage
  • Corticosterone / blood
  • Corticotropin-Releasing Hormone / metabolism*
  • GABA-A Receptor Agonists / administration & dosage
  • GABA-A Receptor Antagonists / administration & dosage
  • Male
  • Membrane Potentials / drug effects
  • Muscimol / administration & dosage
  • Neural Inhibition*
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / physiology*
  • Paraventricular Hypothalamic Nucleus / drug effects
  • Paraventricular Hypothalamic Nucleus / metabolism
  • Paraventricular Hypothalamic Nucleus / physiopathology*
  • Pyridazines / administration & dosage
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA-A / physiology
  • Sodium Potassium Chloride Symporter Inhibitors / administration & dosage
  • Solute Carrier Family 12, Member 2 / metabolism*
  • Stress, Psychological / metabolism
  • Stress, Psychological / physiopathology*
  • Up-Regulation
  • gamma-Aminobutyric Acid / physiology*

Substances

  • GABA-A Receptor Agonists
  • GABA-A Receptor Antagonists
  • Pyridazines
  • Receptors, GABA-A
  • Slc12a2 protein, rat
  • Sodium Potassium Chloride Symporter Inhibitors
  • Solute Carrier Family 12, Member 2
  • Bumetanide
  • Muscimol
  • gamma-Aminobutyric Acid
  • Corticotropin-Releasing Hormone
  • gabazine
  • Corticosterone